Prostate cancer is the third most common cancer in men world-wide and the incidence has been rising 1.7% per year for the last 15 years (1).  It is generally only observed in men over the age of 50 years.  Adenocarcinoma is the most common form of prostate cancer though undifferentiated prostate cancer, squamous cell carcinoma, and ductal transitional carcinoma also occur.  Hormonal influences contribute to adenocarcinoma but almost certainly not to other types of prostate